• Exchange: Xetra
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

EVT:GR

3.500 EUR 0.074 2.07%

As of 15:39:39 ET on 04/17/2014.

Snapshot for Evotec AG (EVT)

Open: 3.604 Day's Range: 3.450 - 3.604 Volume: 891,043
Previous Close: 3.574 52wk Range: 2.100 - 5.175 1-Yr Rtn: +67.87%

Stock Chart for EVT

No chart data available.
  • EVT:GR 3.500
  • 1D
  • 1M
  • 1Y
3.574
Interactive EVT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 112.9032
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -0.2094
Est. EPS (EUR) (12/2014) 0.0310
Est. PEG Ratio 2.3041
Market Cap (M EUR) 460.28
Shares Outstanding (M) 131.51
30 Day Average Volume 796,666
Price/Book (mrq) 2.5603
Price/Sale (ttm) 4.9525
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVT

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVT

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Colin BondCFO/Member-Mgmt BoardMario PolywkaCOO/Member-Mgmt Bd
Cord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil